Recombinant Human Coagulation Factor IX Protein, CF

Catalog # Availability Size / Price Qty
Recombinant Human Coagulation Factor IX Protein Enzyme Activity
1 Image
Product Details
Citations (1)
Supplemental Products

Recombinant Human Coagulation Factor IX Protein, CF Summary

Product Specifications

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<1.0 EU per 1 μg of the protein by the LAL method.
Measured by its ability to cleave the fluorogenic peptide substrate, Mca-RPKPVE-Nval-WRK(Dnp)-NH2 (Catalog # ES002). The specific activity is >30 pmol/min/μg, as measured under the described conditions.
Human embryonic kidney cell, HEK293-derived human Coagulation Factor IX protein
Thr29-Thr461, with a C-terminal Fc tag
Accession #
N-terminal Sequence
Thr29 (pro-mature) and Tyr47 (mature)
Predicted Molecular Mass
75 kDa
86-104 kDa, reducing conditions

Complete Your Research

Product Datasheets

You must select a language.



Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.


Formulation Supplied as a 0.2 μm filtered solution in Tris and NaCl.
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after opening.

Assay Procedure

  • Assay Buffer: 100 mM Tris, 10 mM CaCl2, 150 mM NaCl, 0.05% (w/v) Brij-35, pH 8.0
  • Recombinant Human Coagulation Factor IX (rhFactor IX) (Catalog # 9260-SE)
  • Bacterial Thermolysin (Thermolysin) (Catalog # 3097-ZN)
  • Substrate: Fluorogenic Peptide Substrate II, MCA-Arg-Pro-Lys-Pro-Val-Glu-NVAL-Trp-Arg-Lys(DNP)NH2 (Catalog # ES002)
  • 1,10-Phenanthroline (Sigma, Catalog # 320056)
  • F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
  • Fluorescent Plate Reader (Model: SpectraMax Gemini EM by Molecular Devices) or equivalent
  1. Activate rhFactor IX at 100 µg/mL wih 10 µg/mL Thermolysin in Assay Buffer.
  2. Incubate at 37 °C for 90 minutes.
  3. Stop the reaction by adding 1,10-Phenanthroline to the reaction tube at a final concentration of 10 mM.
  4. Dilute activated rhFactor IX to 4 ng/µL in Assay Buffer.
  5. Dilute Substrate to 20 µM in Assay Buffer.
  6. Load 50 µL of the 4 ng/µL rhFactor IX into a black well plate, and start the reaction by adding 50 µL of 20 µM Substrate.  Include a Substrate Blank containing 50 µL Assay Buffer and 50 µL 20 µM Substrate.
  7. Read at excitation and emission wavelengths of 320 nm and 405 nm (top read), respectively, in kinetic mode for 5 minutes.
  8. Calculate specific activity:

     Specific Activity (pmol/min/µg) =

Adjusted Vmax* (RFU/min) x Conversion Factor** (pmol/RFU)
amount of enzyme (µg)

      *Adjusted for Substrate Blank
      **Derived using calibration standard MCA-Pro-Leu-OH (Bachem, Catalog # M-1975)

Per Well:
  • rhFactor IX: 0.2 µg
  • Substrate: 10 µM

Scientific Data

Enzyme Activity Recombinant Human Coagulation Factor IX Protein Enzyme Activity View Larger

Recombinant Human Coagulation Factor IX (Catalog # 9260-SE) is measured by its ability to cleave the fluorogenic peptide substrate, MCA-RPKPVE-Nval-WRK(Dnp)-NH2 (Catalog # ES002).

Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Background: Coagulation Factor IX

Coagulation Factor IX, also known as Christmas Factor, is a secreted by the liver and plays a key role in the activation of the intrinsic clotting cascade (1). Factor IX consists of a Gla domain, two tandem EGF-like domains, an activation peptide, and an S1 serine protease domain (2). Mature human Factor IX shares approximately 81% amino acid sequence identity with mouse and rat Factor IX. Alternative splicing generates an additional isoform that lacks the first EGF-like domain. The Gla domain is modified by Vitamin K-dependent gamma-carboxylation and mediates the association of Factor IX with phospholipid bilayers (3, 4). The activation peptide is removed by Factor XIa mediated cleavage, resulting in heavy and light chains that remain disulfide-linked (5). Factor IX can also be activated by proteolytic factors in multiple snake venoms (6, 7). Active Factor IX associates with Factor VIIIa on the platelet surface where it cleaves and activates Factor X, leading to Fibrin deposition and clot formation (8-10). The human Factor IX gene is highly polymorphic, and Hemophilia B can be caused by X-linked deficiency of Factor IX activity (11-14).

  1. Smith, S.A. et al. (2015) Crit. Rev. Biochem. Mol. Biol. 50:326.
  2. Kurachi, K. and E.W. Davie (1982) Proc. Natl. Acad. Sci. USA 79:6461.
  3. Rawala-Sheikh, R. et al. (1992) Blood 79:398.
  4. Freedman, S.J. et al. (1996) J. Biol. Chem. 271:16227.
  5. Di Scipio, R.G. et al. (1978) J. Clin. Invest. 61:1528.
  6. Takeya, H. et al. (1992) J. Biol. Chem. 267:14109.
  7. Sajevic, T. et al. (2011) Toxicon 57:627.
  8. Ahmad, S.S. et al. (2003) J. Thromb. Haemost. 1:2348.
  9. Mathur, A. et al. (1997) J. Biol. Chem. 272:23418.
  10. van Dieijen, G. et al. (1985) Thromb. Haemost. 53:396.
  11. Aguilar-Martinez, P. et al. (1994) Hum. Genet. 94:287.
  12. Davis, L.M. et al. (1987) Blood 69:140.
  13. Bertina, R.M. et al. (1990) J. Biol. Chem. 265:10876.
  14. Girolami, A. et al. (2015) Semin. Thromb. Hemost. 41:359.
Entrez Gene IDs
2158 (Human); 14071 (Mouse); 24946 (Rat)
Alternate Names
Christmas Factor; Coagulation Factor IX; EC 3.4.21; EC; F9; factor 9; FIX; HEMB; MGC129641; MGC129642; P19; Plasma Thromboplastic Component; Plasma thromboplastin component; PTC; THPH8

Citation for Recombinant Human Coagulation Factor IX Protein, CF

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

1 Citation: Showing 1 - 1

  1. Genome wide CRISPR/Cas9 screen identifies the coagulation factor IX (F9) as a regulator of senescence
    Authors: P Carpintero, M Borghesan, O Eleftheria, B Pan-Castil, JA Fafián-Lab, TP Mitchell, A Yuste, M Ogrunc, TD Nightingal, M Mayan, A O'Loghlen
    Cell Death & Disease, 2022;13(2):163.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay


No product specific FAQs exist for this product, however you may

View all Proteins and Enzyme FAQs

Fluorogenic Peptide Substrates

Reviews for Recombinant Human Coagulation Factor IX Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Human Coagulation Factor IX Protein, CF and earn rewards!

Have you used Recombinant Human Coagulation Factor IX Protein, CF?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review